Cytek Biosciences Inc (CTKB)
6.095
-0.08
(-1.38%)
USD |
NASDAQ |
May 17, 16:00
6.095
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Enterprise Value: 534.09M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 534.09M |
| May 16, 2024 | 544.60M |
| May 15, 2024 | 534.09M |
| May 14, 2024 | 560.35M |
| May 13, 2024 | 544.60M |
| May 10, 2024 | 560.35M |
| May 09, 2024 | 547.22M |
| May 08, 2024 | 556.41M |
| May 07, 2024 | 570.85M |
| May 06, 2024 | 576.10M |
| May 03, 2024 | 549.85M |
| May 02, 2024 | 547.22M |
| May 01, 2024 | 569.54M |
| April 30, 2024 | 522.28M |
| April 29, 2024 | 524.85M |
| April 26, 2024 | 489.41M |
| April 25, 2024 | 472.35M |
| April 24, 2024 | 476.29M |
| April 23, 2024 | 495.98M |
| April 22, 2024 | 494.66M |
| April 19, 2024 | 510.41M |
| April 18, 2024 | 515.67M |
| April 17, 2024 | 510.41M |
| April 16, 2024 | 516.98M |
| April 15, 2024 | 523.54M |
| Date | Value |
|---|---|
| April 12, 2024 | 543.23M |
| April 11, 2024 | 560.30M |
| April 10, 2024 | 553.73M |
| April 09, 2024 | 640.37M |
| April 08, 2024 | 612.80M |
| April 05, 2024 | 591.73M |
| April 04, 2024 | 585.17M |
| April 03, 2024 | 594.36M |
| April 02, 2024 | 589.11M |
| April 01, 2024 | 612.73M |
| March 31, 2024 | 614.05M |
| March 28, 2024 | 617.63M |
| March 27, 2024 | 607.17M |
| March 26, 2024 | 562.69M |
| March 25, 2024 | 575.77M |
| March 22, 2024 | 586.23M |
| March 21, 2024 | 604.55M |
| March 20, 2024 | 616.32M |
| March 19, 2024 | 616.32M |
| March 18, 2024 | 629.41M |
| March 15, 2024 | 649.03M |
| March 14, 2024 | 632.02M |
| March 13, 2024 | 621.56M |
| March 12, 2024 | 637.26M |
| March 11, 2024 | 684.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
270.00M
Minimum
Oct 30 2023
3.575B
Maximum
Sep 15 2021
1.280B
Average
1.065B
Median
Enterprise Value Benchmarks
| Ainos Inc | 11.19M |
| OpGen Inc | 13.51M |
| Zomedica Corp | 87.26M |
| LENSAR Inc | 29.05M |
| Eargo Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.169M |
| Revenue (Quarterly) | 44.86M |
| Total Expenses (Quarterly) | 55.59M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 51.30% |
| Profit Margin (Quarterly) | -13.75% |
| Earnings Yield | -1.48% |
| Normalized Earnings Yield | -1.475 |